Resources

Human papillomavirus (HPV) vaccine programs in low- and middle-income countries face financial, programmatic, and social barriers to the introduction and sustainability of these programs. An HPV vaccine delivered through a microarray patch (MAP) could offer potential advantages to address some of those barriers. We asked global experts and stakeholders in Ethiopia about the acceptability and programmatic suitability of this option. In this report, we share the input from these stakeholders, both in terms of programmatic advantages and concerns regarding an HPV vaccine MAP, as well as some of their desired attributes.

Noncommunicable diseases (NCDs), such as cardiovascular disease, cancer, and diabetes, are the leading cause of mortality in the world. Every year, 41 million people die from NCDs, 15 million of them between the ages of 30 and 69. Despite the many proven solutions, progress has been slow and uneven globally. This document provides an overview of the NCD ecosystem, a description of primary findings, and recommendations for future action. Findings and recommendations are presented across four pillars—Access, Integrated Models of Care, Capacity Building, and Sustainability Efforts—to organize the information and analysis with a view toward the prioritization of gaps and opportunities for intervention and partnership, especially for non-state actors.The landscape identifies several enabling factors required to address the key barriers impacting NCD care, alongside intervention opportunities with a specific focus on hypertension and diabetes. The enabling factors are organized into four quadrants adapted from the WHO’s NCD capacity domains and subsequently mapped along a pathway to scale to identify archetypes of country capacity levels. The assessment is timely as countries set their universal health coverage (UHC) roadmaps.

Drawing on four decades of advocacy experience, PATH aims to play a catalytic role in advancing the practice of advocacy in health through fostering knowledge sharing, connection and collaboration among health advocates and other stakeholders. This learning brief highlights key takeaways from a virtual conversation between civil society advocates and a policymaker from Kenya, Uganda, and Burkina Faso about experiences and lessons in engaging policymakers for agenda and priority setting around PHC systems and policy implementation at national and regional levels.

S'appuyant sur quatre décennies d'expérience en matière de plaidoyer, PATH entend jouer un rôle de catalyseur pour promouvoir la pratique du plaidoyer dans le domaine de la santé en favorisant les échanges de connaissances, la connexion et la collaboration entre les acteurs de plaidoyer pour la santé et les autres parties prenantes. Ce dossier d'apprentissage met en lumière les principaux enseignements d'une conversation virtuelle entre les acteurs de la société civile et un responsable politique du Kenya, de l'Ouganda et du Burkina Faso sur les expériences et les leçons tirées de l'engagement des responsables politiques dans la définition de l'agenda et des priorités concernant les systèmes de SSP (soins de santé primaire) et la mise en œuvre des politiques aux niveaux national et régional.

For more than a decade, PATH has supported the adoption of evidence-based, adequately-resourced, and impactful policies. We work side by side with national and subnational government to advance evidence-based policymaking and to ensure civil society is engaged in these processes. For greater impact and sustainability, we partner with local civil society organizations (CSOs), enabling them to lead and demand accountability from governments. This document provides an orientation to our approaches to supporting governments and civil-society partners engaging in policy advocacy, highlights how our approaches and tools have been used and adapted to context, and captures our learnings.